Sign in
Retrospective review of Her2 positive metastatic breast cancer patients who received Pertuzumab and Herceptin as a first line therapy at KFSH&RC (single institute experience) from 2013 to 2016
Journal article   Peer reviewed

Retrospective review of Her2 positive metastatic breast cancer patients who received Pertuzumab and Herceptin as a first line therapy at KFSH&RC (single institute experience) from 2013 to 2016

K. Suleman, A. Mushtaq, E. Haque, A. Badran, D. Ajarim, T. Tweigeri, A. Elashwah, A. Shahin, K. Khan and A. Alsayed
Breast (Edinburgh), Vol.44, p.S64
03/2019

Metrics

1 Record Views

Details